Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease-Reference-Cited by-同舟云学术

Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease

Published:2019-07 Issue:7 Volume:6 Page:1248-1262
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Pillai Jagan A.¹²³^ORCID,Maxwell Sean⁴⁵,Bena James⁶,Bekris Lynn M.⁷,Rao Stephen M.¹²,Chance Mark⁴⁵,Lamb Bruce T.⁸,Leverenz James B.¹²³,

Affiliation:

1. Lou Ruvo Center for Brain Health Cleveland Clinic Cleveland Ohio 44195

2. Neurological Institute Cleveland Clinic Cleveland Ohio 44195

3. Department of Neurology Cleveland Clinic Cleveland Ohio 44195

4. Center for Proteomics and Bioinformatic Case Western Reserve University Cleveland Ohio 44106

5. Department of Nutrition Case Western Reserve University Cleveland Ohio 44106

6. Quantitative Health Sciences Cleveland Clinic Cleveland Ohio 44195

7. Genomic Medicine Institute Cleveland Clinic Cleveland Ohio 44195

8. Stark Neuroscience Research Institute Indiana University School of Medicine Indianapolis Indiana 46202

Funder

National Institute on Aging

Alzheimer's Association

U.S. Department of Defense

National Institute of Biomedical Imaging and Bioengineering

AbbVie

BioClinica

Biogen

Bristol-Myers Squibb

Eisai

Elan

Eli Lilly and Company

Roche

Genentech

Fujirebio Europe

GE Healthcare

Johnson and Johnson

Merck

Meso Scale Diagnostics

Novartis

Pfizer

Takeda Pharmaceutical Company

Health Research

National Institutes of Health

Northern California Institute for Research and Education

University of Southern California

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.50827

Reference53 articles.

1. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?;Wyss‐Coray T;Nat Med,2006

2. Alzheimer Disease in 2020

3. Longitudinal Inflammation, Cognitive Decline, and Alzheimer’s Disease: A Mini-Review

4. Systemic infections and inflammation affect chronic neurodegeneration

5. Systemic inflammation and disease progression in Alzheimer disease

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity of cerebral atrophic rate in mild cognitive impairment and its interactive association with proteins related to microglia activity on longitudinal cognitive changes;Archives of Gerontology and Geriatrics;2024-12

2. Neuroinflammation: A Critical Factor in Neurodegenerative Disorders;Cureus;2024-06-13

3. Evaluation and Characterization of Modified K114 Method to Localize Plaques in Rodent and Plaques and Tangles in Human Brain Tissue;Current Alzheimer Research;2024-01

4. White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer’s disease continuum;Neurobiology of Aging;2023-12

5. The neutrophil-to-lymphocyte ratio is associated with mild cognitive impairment in community-dwelling older women aged over 70 years: a population-based cross-sectional study;Frontiers in Aging Neuroscience;2023-09-14